NCT03263455

Brief Summary

Stroke is the second leading cause of death worldwide and the third most common cause of disability. The effects of stroke are variable and may include impairments in motor and sensory systems, emotion and neuropsychological deficits such as a disorder of spatial awareness known as unilateral spatial neglect (USN). Approaches to ameliorate USN could be categorized in interventions as involving either bottom-up or top-down processing. The specific mechanisms underlying these effects on a number of manifestations of the USN syndrome may include the restoration of defective representations of the side of space contralateral to the lesion (contralesional), and of the ability to orient spatial attention contralesionally, through complex patterns of activation of both the damaged right hemisphere, and the contralateral left hemisphere, with differences related to the specific stimulation delivered to the patient. In recent years, increasing cutaneous stimuli through neuromuscular kinesiotaping has been proposed to enhance somatosensory inputs (24) and such as method could have positive effects on USN. The aim of the present study was to assess the effect of KTM applied on the sternocleidomastoid muscle controlateral side of the lesions in improving USN deficits in individuals with stroke patient in sub-acute phase. The hypothesis is that the KTM application could improved cognitive tests for assessing USN, motor deficits and kinesthetic neck sensibility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Sep 2017

Shorter than P25 for not_applicable stroke

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

August 28, 2017

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2017

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2018

Completed
Last Updated

August 28, 2017

Status Verified

August 1, 2017

Enrollment Period

3 months

First QC Date

August 14, 2017

Last Update Submit

August 25, 2017

Conditions

Keywords

neglect,stroke,rehabilitation,range of motion

Outcome Measures

Primary Outcomes (1)

  • The Stars Cancellation Test change in number of stars deleted

    Baseline time 0 and up to 4 weeks

Secondary Outcomes (3)

  • Number of letter delete during the Letter Cancellation Test

    Baseline time 0 and up to 4 weeks

  • Number of Error assessed during the Cervical Joint Position Error Test

    Baseline time 0 and up to 4 weeks

  • Degree of Active Range of Motion (AROM) during left rotation

    Baseline time 0 and up to 4 weeks

Study Arms (2)

Kinesio Taping group

EXPERIMENTAL

The tape in the KT group was applied with paper-off tension, which means applying the tape directly to the skin as it comes off the paper backing (approximately with 15% to 25% of available tension).

Other: Kinesio taping group

Sham Taping group

SHAM COMPARATOR

Patients in the ST group, smaller "I-strips" of KinesioTape were used and they were applied, with no tension and without stretching the muscles, perpendicularly to the muscle belly (starting from the middle and progressing to each side) over the same dystonic muscles as in the Kinesio Taping group

Other: Sham Taping

Interventions

The tape in the KT group will be applied with paper-off tension, which means applying the tape directly to the skin as it comes off the paper backing (approximately with 15% to 25% of available tension). KinesioTape will be applied over the SCM dystonic muscle by means of 2 "I-strips": the first strip will be placed on the medial (sternal) head and the second will be applied on the lateral (clavicular) head of the SCM muscle. KinesioTape was applied from the mastoid bone to the clavicle (rostrocaudal direction) with the SCM placed in a position of maximum stretching.

Kinesio Taping group

Patients in the ST group, smaller "I-strips" of KinesioTape will be used and they will be applied, with no tension and without stretching the muscles, perpendicularly to the muscle belly (starting from the middle and progressing to each side) over the same dystonic muscles as in the experimental group. Although the specific therapeutic elements of KinesioTaping (ie, longitudinal stretch, start and ending point tape application) will be removed

Sham Taping group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients affected by stroke from cerebral ischemia or hemorrhage that occurred ⩽ 30 days before;
  • presence of visuospatial neglect (Star Cancellation Test' score \< 50)
  • able to actively rotate the head toward left side in closed eyes condition.

You may not qualify if:

  • the presence of dementia (Mini-Mental State Examination correct score lower than 23,80)
  • severe deficit of comprehension
  • psychiatric disorders
  • hemianopsia patients (diagnosed with perimetry) patients or their family members did not consent to this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Azienta Ospedaliera, SSO Rehabilitation Unit, Verona

Verona, Italy, Verona, 37134, Italy

Location

Azienta Ospedaliera, SSO Rehabilitation Unit, Verona

Verona, 37134, Italy

Location

MeSH Terms

Conditions

StrokeMotor Disorders

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMental Disorders

Study Officials

  • Nicola Smania, MD

    Neuromotor and Cognitive Rehabilitation Center Department for Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy P.zza L.A. Scuro, 10 37134 Verona, Italia

    PRINCIPAL INVESTIGATOR
  • Alessandro Picelli, MD

    Neuromotor and Cognitive Rehabilitation Center Department for Neurosciences, Biomedicine and Movement Sciences University of Verona, Verona, Italy P.zza L.A. Scuro, 10 37134 Verona, Italia

    STUDY DIRECTOR

Central Study Contacts

Valentina Varalta, PS

CONTACT

Daniele Munari, PT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

August 14, 2017

First Posted

August 28, 2017

Study Start

September 1, 2017

Primary Completion

November 30, 2017

Study Completion

August 1, 2018

Last Updated

August 28, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations